OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
March 02, 2020
The huge potential of biopharma is presenting an important epoch for outsourcing partners that can support the development and manufacture of biologics in an efficient way.
As compounds become more multifaceted and biological ingredients are more commonly utilized, stability testing tactics must follow suit and ensure flexibility for developers.
Metrology has the potential to not only avoid damage to patients but also to encourage novel therapeutic opportunities.
February 02, 2020
Amid the rapidly rising cases of a novel coronavirus, concerns are being raised over preparedness and potential disruptions to the pharma supply chain.
Lipid-based solutions offer a natural approach to improving the solubility of cannabinoid-derived products.
February 01, 2020
As cell and gene therapies become more prominent, industry is seeking the expertise and capabilities of outsourcing partners to ensure success.